Antifreeze glycoprotein (AFGP)

Antifreeze glycoproteins (AFGPs) are a specialized class of proteins found in the blood and tissues of various cold-adapted organisms, most notably Antarctic notothenioids and Arctic cod [3, 6]. These molecules are characterized by a repeating tripeptide motif, typically Alanine-Alanine-Threonine (Ala-Ala-Thr), with a disaccharide (galactose-N-acetylgalactosamine) attached to the threonine residue [1, 9]. Their primary biological function is to prevent the growth of ice crystals through an adsorption-inhibition mechanism, where they bind to specific planes of embryonic ice crystals to create a "thermal hysteresis" effect—lowering the freezing point of body fluids without significantly affecting the melting point [11, 13]. This allows organisms to survive in sub-zero environments where their body fluids would otherwise freeze [9]. In a therapeutic and biotechnological context, AFGPs are not traditional drug targets but are instead investigated as cryoprotective agents for the preservation of cells, tissues, and organs intended for transplantation [5, 7]. They are also utilized in cryosurgery to enhance the mechanical destruction of solid tumors by promoting the formation of lethal bipyramidal ice crystals [2, 8]. While they offer significant potential for improving post-thaw viability in regenerative medicine, challenges include their high cost of isolation from natural sources, potential immunogenicity, and dose-dependent toxicity in certain mammalian cell types like hepatocytes [12, 14, 15].

Other names

Ice structuring proteinIce-binding proteinThermal hysteresis proteinAntifreeze glycopeptideAFGP 1-8

Not applicable; antifreeze glycoproteins are typically utilized as therapeutic agents or cryoprotectants rather than serving as targets for drug inhibition. Their own mechanism involves adsorption-inhibition on ice crystal surfaces.